Committed to enabling the next generation of biological cancer drugs

At Perspix Biotech we bring together proven specialists from areas of digital technology integration and biological drug development with renowned company builders and commercial experts.

Committed to enabling the next generation of biological cancer drugs

At Perspix Biotech we bring together proven specialists from areas of digital technology integration and biological drug development with renowned company builders and commercial experts.

Adding to our in-depth know-how are the insights and experiences of our distinguished advisors. They will be central to establish Perspix Biotech as the leading company for the creation of next-generation multi-targeting cancer therapeutics.

Dr. Matthias Wiedenfels

Managing Director & CEO

Leadership

Dr. José Airas

Managing Director & COO

Leadership

Dr. Jörg Birkenfeld

CSO

Leadership

Prof. Dr. mult. Hartmut Michel

Biochemist & Nobel Laureate in Chemistry

Scientific Road Map, Advisory Board

Dr. Tomás Tomeo

Economist & Corporate Development Expert

Liaison Management, Advisory Board

Ivan Kugener, MD

Corporate Finance Advisor & Industry Expert

US Representative

Adding to our in-depth know-how are the insights and experiences of our distinguished advisors. They will be central to establish Perspix Biotech as the leading company for the creation of next-generation multi-targeting cancer therapeutics.

Dr. Matthias Wiedenfels

Managing Director & CEO

Leadership

Dr. José Airas

Managing Director & COO

Leadership

Dr. Jörg Birkenfeld

CSO

Leadership

Prof. Dr. mult. Hartmut Michel

Distinguished Biochemist & Nobel Laureate in Chemistry

Scientific Road Map, Advisory Board

Dr. Tomás Tomeo

Economist & Corporate Development Expert

Liaison Management, Advisory Board

Ivan Kugener, MD

Corporate Finance Advisor & Industry Expert

US Representative

Now it is time for change

Copyright 2022 Perspix Biotech  |  All rights reserved

Copyright 2022 Perspix Biotech  |  All rights reserved